TRML - Tourmaline Bio, Inc.
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
|
PRICE TARGET:
$48.50
DETAILS
HIGH:
$50.00
LOW:
$47.50
MEDIAN:
$48.00
CONSENSUS:
$48.50
UPSIDE:
1.08%
Profitability Ratios
| Ratio | Value |
|---|---|
| GP Margin | 0.0% |
| EBIT Margin | 0.0% |
| EBITDA Margin | 0.0% |
| Operating Margin | 0.0% |
| Pretax Margin | 0.0% |
| Cont. Ops Margin | 0.0% |
| Net Margin | 0.0% |
| Bottom Line Margin | 0.0% |
Liquidity Ratios
| Ratio | Value |
|---|---|
| Current Ratio | 30.18 |
| Quick Ratio | 30.18 |
| Solvency Ratio | -10.027 |
| Cash Ratio | 3.42 |
Valuation Ratios
| Ratio | Value |
|---|---|
| Price/Earnings |
-7.02
Peers avg: 13.0
|
| PEG Ratio | 0.10 |
| Forward PEG | 0.10 |
| Price/Book | 1.71 |
| Price/Sales | 0.00 |
| Price/FCF | -6.65 |
| Price/Op Cash Flow | -6.65 |
Debt Ratios
| Ratio | Value |
|---|---|
| Debt/Assets | 0.0008 |
| Debt/Equity | 0.0008 |
| Debt/Capital | 0.0008 |
| Long-Term Debt/Capital | 0.0000 |
| Financial Leverage | 1.03 |
Cash Flow Ratios
| Ratio | Value |
|---|---|
| Working Capital Turnover | 0.00 |
| Operating Cash Flow Ratio | -8.672 |
| Operating Cash Flow/Sales | 0.0% |
| Free Cash Flow/Operating Cash Flow | 100.0% |
Coverage Ratios
| Ratio | Value |
|---|---|
| Debt Service Coverage | 0.00 |
| Interest Coverage | 0.0000 |
| Short-Term Operating Cash Flow Coverage | 0.00 |
| Operating Cash Flow Coverage | -316.65 |
| Capital Expenditure Coverage | -8584.78 |
| Dividend + Capital Expenditure Coverage | -8584.78 |
Dividend Ratios
| Ratio | Value |
|---|---|
| Payout Ratio | 0.0000% |
| Dividend Yield | 0.0000% |
| Dividend Yield % | 0.0000% |
| Dividend Per Share | 0.0000 |
Per Share Ratios
| Ratio | Value |
|---|---|
| Revenue/Share | 0.00 |
| EPS | -2.888 |
| Debt/Share | 0.0096 |
| Cash/Share | 10.19 |
| Book Value/Share | 11.84 |
| Tangible BV/Share | 11.84 |
| Equity/Share | 11.84 |
| Operating Cash Flow/Share | -3.048 |
| Capital Expenditure/Share | 0.000 |
| FCF/Share | -3.048 |
Other Ratios
| Ratio | Value |
|---|---|
| Net Income/Earnings Before Tax | 1.000 |
| Earnings Before Tax/EBIT | 0.816 |
| Price/Fair Value | 1.71 |
| Debt/Market Cap | 0.0000 |
| Effective Tax Rate | 0.0% |
| Enterprise Value Multiple | -5.39 |